The mechanism of action of 2', 3'-dideoxythymidine analogues such as azidothymidine (AZT) and fluorothymidine (FLT) is thought to be chain termination and inhibition of reverse transcriptase by the triphosphate. However, little triphosphate is formed intracellularly relative to monophosphate and diphosphate. Azidothymidine and fluorothymidine are phosphorylated intracellularly by the thymidine salvage pathway and therefore must compete with thymine nucleotides for phosphorylation, which may limit the rate of phosphorylation. We have investigated the degree to which competition with thymidine limits the phosphorylation of azidothymidine and fluorothymidine. In this paper we show that inhibition of thymidylate synthase by 5-fluoro-2'-deoxyuridine monophosphate increases the phosphorylation of azidothymidine and fluorothymidine by reducing the pools of thymine nucleotides and therefore removing the competition. 5-fluoro-2'-deoxyuridine abolished the pools of TTP and dGTP and caused the appearance of dUTP in treated lymphocytes. Three times more triphosphate was formed in cells treated with 5-fluoro-2'-deoxyuridine. Ten times more fluorothymidine triphosphate than azidothymidine triphosphate was formed. The results suggest that while competition with intracellular thymine nucleotides does hinder the phosphorylation of AZT and FLT, the major limiting factor is their ability to act as substrates for the phosphorylating enzymes.
Introduction
Several compounds have to date been tested as inhibitors Received 1 February, 1990; revised 21 March, 1990 . *Forcorrespondence. Tel. 46 8 7351000; Fax 4687303248. of human immunodeficiency virus (HIV) replication. The largest and most active group of compounds comprise the 2',3'-dideoxynucleoside analogues (Mitsuya et al., 1985; Herdewijn et al., 1987; Kim et al., 1987; Balzarini et al., 1988a,b; Bazin et al., 1989) . The most active dideoxynucleoside is 3' -fluoro-3'-deoxythymidine (FLT; Balzarini et al., 1988a; Hartmann et al., 1988; Matthes et al., 1988; Koshida et al., 1989) , which reduces HIV replication by 50% at 0.001-0.005 f.LM (Balzarini et al., 1988a; Matthes et al., 1988) . The only dideoxynucleoside licensed to date for the treatment of acquired immune deficiency syndrome (AIDS) patients is 3' -azido-3'-deoxythymidine (AZT; Fischl et al., 1987) . The clinical usefulness of AZT is, however, limited by its toxicity (Richman et aI., 1987) . In addition, HIV strains resistant to AZT have been isolated from AIDS patients undergoing long-term therapy with AZT (Larder et al., 1989) . There is a clear need for alternative therapies to treat HIV infection and AIDS.
The mode of action of 2',3'-dideoxynucleosides such as AZT and FLT is thought to be chain termination of DNA synthesis by the triphosphate, since there is no 3'hydroxyl group to allow further elongation by reverse transcriptase (Furman et al., 1986; Vrang et al., 1987) . The activity of these compounds is thus in part determined by the rate of formation and stability of the triphosphate (Hao et al., 1988) . The amount of triphosphate formed intracellularly has been shown to vary depending on the cells in question, and therefore the activity against HIV varies concomitantly (Balzarini et el., 1988c) . AZT has been shown to accumulate in human cells as AZT monophosphate, and very little of the total intracellular AZT exists as the triphosphate (Furman et al., 1986) . Only the triphosphate of AZT is currently believed to be active against HIV, and the mono-and diphosphates have not been shown to exhibit antiviral activity-conversely, they may in fact be at least partly responsible for the toxic effects of AZT, especially since the intracellular monophosphate can reach millimolar concentrations (Furman et al., 1986) . It is therefore of great interest to determine whether the intracellular triphosphate levels of dideoxynucleosides such as AZT can be increased, especially since Hao et al. (1988) have suggested that the amount of triphosphate dUrd Thd AZT FLT and FLT is maximal or whether it is limited by the need to compete with thymine nucleotides for phosphorylation. 
Results
Effect of 5-FdUrd 5-FdUrd (as the monophosphate) inhibited thymidylate synthase activity in CEM cells completely (Table 1) .At this concentration 5-FdUrd stopped cell growth but did not affect viability of the cells. The pools of deoxynucleoside triphosphates in cells treated with 5-FdUrd were determined and are shown in Table 2 . TIP was reduced to below detectable levels. The dGTP pool was also greatly reduced compared to untreated cells. dUTP, which was not detectable in untreated cells, was also found in the 5-FdUrd-treated cells. formed intracellularly is the major factor in determining antiviral activity. AZT and FLT are thymidine analogues and are phosphorylated intracellularly by the thymidine salvage pathway ( Fig. 1 ).They must therefore compete with the natural thymine nucleoside and nucleotides for phosphorylation. AZT is well phosphorylated by thymidine kinase (Furman et al., 1986) , but AZT monophosphate is poorly phosphorylated by TMP kinase. A reduction in the levels of intracellular thymine nucleotides, especially TMP, should therefore facilitate the phosphorylation of AZT.
Thymidylate synthase is the enzyme responsible for the de novo synthesis of thymine nucleotides. It catalyses the reductive methylation of dUMP to form TMP ( Fig. 1 ; Danenberg, 1977) . The enzyme has been well studied since it is a target for anti-cancer chemotheraphy (Danenberg, 1977) , and several fluorinated pyrimidines, such as 5-fluoro-2'-deoxyuridine (5-FdUrd), have been shown to be potent inhibitors (as the monophosphate) of thymidylate synthase (Danenberg and Lockshin, 1981) .
We therefore decided to determine whether inhibition of thymidylate synthase by 5-FdUrd monophosphate could increase intracellular levels of AZT and FLT triphosphates by reducing the competition for phosphorylation with the natural thymine nucleotides. This would indicate whether the previously observed rate of phosphorylation of AZT Table 1 . ThymidyJate synthase activity in intact cells. 5 x 10 6 cells were incubated at 37°C with 1 /LCi[5-3H]-2' -deoxyuridine for 2 h. Unconverted labelled substrate was removed by addition of 50 mg charcoal and centrifugation. 1ml of the supernatant (containing 3H~0 formed in the reaction) was taken for scintillation counting. The mean of four determinations is shown. Trichloroacetic acid was added to the control cells immediately after addition of labelled substrate.
16189 2470
Thymidylate synthase activity measured as 3H 20 produced in 2 h (c.p.m.)
CEM cells CEM cells incubated with 500nM 5-FdUrd Control

Amount of FLT and AZT triphosphate formed during thymidylate synthase inhibition
The amount of FLT and AZT triphosphate formed in cells with and without inhibition of thymidylate synthase is shown in Fig. 2 . Approximately 10 times more FLT triphosphate was formed in CEM cells compared to AZT
Effect of FLT and AZT upon cellular dNTP pools
The deoxynucleoside triphosphate pools in cells treated with 0.1 fLM FLTor AZT are shown in Table 2 . FLT reduced the TIP pool to about half that in untreated cells. A slight reduction in the dATP and dGTP pools was also seen. AZT reduced the TIP pool to a greater extent, to about a quarter that in untreated cells.
The effect of the combination of FLT or AZT with 5-FdUrd on dNTP pools is also shown in Table 2 . The combination of FLT and 5-FdUrd abolished TIP and dGTP completely and reduced the dATP pool. The dUTP pool was larger than when 5-FdUrd was used alone. The combination of AZT and 5-FdUrd reduced TIP and dGTP to small but measurable amounts. No dUTP was found when AZT and 5-FdUrd were used together. 
Amount of FLT and AZT monophosphate formed in cells
The amount of FLT and AZT monophosphate formed in cells with and without inhibition of thymidylate synthase by 5-FdUrd monophosphate is shown in Fig. 3 . Complete inhibition of thymidylate synthase by 5-FdUrd monophosphate increased the amount of monophosphate formed when 0.1 fLM FLT was used, and when 0.1 or 0.05 fLM AZT was used. There was no increase at 0.01 fLM AZT or at 0.01 fLM and 0.05 fLM FLT.
Discussion
triphosphate. Complete inhibition of thymidylate synthase by 5-FdUrd monophosphate increased the amount of FLT and AZT triphosphate formed intracellularly by threefold when 0.1 fLM nucleoside analogue was used. 0.10 0.04 0.06 0.08
5-FdUrd is phosphorylated intracellularly to form 5-FdUrd monophosphate, a potent inhibitor of thymidylate synthase (Oanenberg and Lockshin, 1981) . Incubation of CEM cells with 500 nM 5-FdUrd completely inhibited thymidylate synthase activity and had a profound effect on the dNTP pools. The TIP pool was completely abolished and the dGTP pool was severely reduced. Similar changes have been observed in mouse cells incubated with 5-FdUrd (Yoshioka et el., 1987) , along with an expansion of the dATP pool. We did not see a convincing enlargement of the dATP pool in CEM cells. dUTP, which was not detectable in untreated cells, was also present in 5-FdUrdtreated CEM cells, in agreement with previous studies (Ingraham et al., 1981) .
The disappearance of the TIP pool is presumably a direct result of inhibition by 5-FdUrd monophosphate of thymidylate synthase, which is responsible for the formation of TMP from dUMP (Fig. 1) . The reduction in the dGTP pool may be a consequence of lowered reduction of GOP by ribonucleotide reductase, since TIP is required to bind to ribonucleotide reductase to facilitate GOP reduction (Eriksson et al., 1979) and we have already shown that TIP is abolished in 5-FdUrd-treated CEM cells. The 0.10 and without inhibition of thymidylate synthase. GEM cells (4 x 10 5/ml) were incubated at 37"G for 24 h with 0.01, 0.05 and 0.1 fLM [5-3H]-AZT or [5-3H]-FL T, with and without inhibition of thymidylate synthase by 500 nM 5-FdUrd. The deoxynucleotides were extracted and separated by ionexchange HPLG as described in the Materials and Experimental procedures. 0.5 min fractions were collected and the total radioactivity in the triphosphate peak determined by scintillation counting. The mean of two separate determinations is shown. The SO, which were too small to show on the figure, were in all cases <10%. (0) no 5-FdUtd; (e) 500 nM 5-FdUrd. GEM cells (4 x 10 5/ml) were incubated for 24h with AZT, FLTand/or 5-FdUrd as indicated. The cells were counted, and the deoxynucleotides extracted and quantified by ion-exchange HPLG as described in the Materials and Experimental procedures. The mean of three determinations is shown ± SO. type of cells used (Furman et a/., 1986; Frick et a/., 1988; Frick and Nelson, 1989) . H9 Iymphoctes incubated with 50fLMAZT for 24h showed a similar reduction in TIP, as we have presented here in GEM cells, but reductions in dGTP and dGTP and an expansion of dATP were also seen (Furman et a/., 1986) . K562 cells also showed a similar drop in TIP when incubated with 200 fLM AZT for 24 h along with increases in dGTP and dATP (Frick and Nelson, 1989) . Increasing doses of AZT were shown to have increasing effects upon dNTP pools, though these effects varied according to the cells examined (Frick and Nelson, 1989) . In some cells the effects have been shown to be transient, with partial restoration after 24h (Frick et a/., 1988) . It is clear that different cells react to AZT differently and this may be owing to their particular rate of metabolism of AZT (Frick and Nelson, 1989) . In our experience incubation of GEM lymphocytes with low concentrations of AZT causes a reduction in TIP that is not restored after 24h.
The concentration of AZT in the plasma of patients reaches approximately 4 fLM 1 h after oral administration of 250 mg AZT and declines to about one-tenth 4 h later (Yarchoan et a/., 1986; Fischl et a/., 1987) . The concentration of AZT used in this study (0.1 fLM) is therefore closer to the mean physiological concentration of AZT than the previous studies using 50 and 200 fLM (Furman et a/., 1986; Frick et a/., 1988) . The changes we observed in the TIP pool may therefore more closely represent those that occur in vivo, and may contribute to the toxic effects of AZT.
The reduction in the TIP pool caused by AZT is probably owing to inhibition of thymidylate kinase by AZT monophosphate, which binds to the enzyme but is very poorly phosphorylated (Furman et a/., 1986) . The reduction in TIP caused by FLT is probably a result of reduced phosphorylation of thymidine owing to the competition with FLT for the phosphorylating enzymes.
When FLTwas incubated together with 5-FdUrd, similar effects upon the dNTP pools were seen to when 5-FdUrd was used alone. When AZT and 5-FdUrd were used together, the same reductions in TIP and dGTP were seen as when 5-FdUrd was used alone, but no dUTP could be seen. This is probably owing to inhibition of thymidylate kinase, which phosphorylates dUMP (Fig. 1) . by AZT monophosphate (Furman et sl., 1986) . Since dUTP was found when FLT and 5-FdUrd were used together, this indicates that, unlike AZT monophosphate, FLT monophosphate probably does not inhibit thymidylate kinase.
The reduction in the TIP pool in the presence of 500 nM 5-FdUrd presumably reflects a reduction in TOP and TMP, owing to the complete inhibition of thymidylate synthase by 5-FdUrd monophosphate. The increased amounts of intracellular FLT and AZT triphosphates formed in the presence of 500 nM5-FdUrd are therefore probably owing appearance of dUTP in 5-FdUrd-treated cells may be expected because inhibition of thymidylate synthase would cause a large increase in the level of dUMP, the substrate for the reaction,and this would therefore increase the production of dUTP (Fig. 1) .
Both FLT and AZT caused a reduction in the TIP pool when incubated alone with GEM cells. The reduction was greater for AZT. Previous research has shown that the effect of AZT upon natural dNTP pools in cells depends on the concentration of AZT, the length of incubation and the to decreased competition between the thymine nucleotides and the analogue for the phosphorylating enzymes (Fig. 1) . The increase in triphosphate levels was only modest (three-fold increase at 0.1 J-LM analogue concentration), even though thymidylate synthase was completely inhibited. At the lower 5-FdUrd concentration of 5 nM (which inhibits intracellular thyrnidylate synthase activity by approximately 50%) no significant increase in the amount of triphosphate formed (at 0.1 J-LM analogue concentration) was seen (data not shown). This indicates that the major impediment to the phosphorylation of AZT and FLT is not competition with thymidine for the phosphorylating enzymes but probably the substrate efficiency of the analogue for one or more of the phosphorylating enzymes.
The amount of monophosphate produced at 0.1 J-LM FLT and at 0.05 and 0.1 J-LM AZT was also increased in the presence of 500nM 5-FdUrd. This probably reflects an increase in thymidine kinase activity owing to lack of inhibition by TIP, as has been suggested previously (Frick and Nelson, 1989) . At 0.05 and 0.01 J-LM FLT and 0.01 J-LM AZT, the rate of phosphorylation to the monophosphate is presumably already maximal and cannot be increased by increasing TK activity.
Ten times more FLT triphosphate was produced compared to AZT triphosphate. This is exactly as expected, since we and others have shown FLT to be 5-10 times more active against HIV replication than AZT (Balzarini et si., 1988a; Hartmann et el., 1988; Koshida et el., 1989) .
The triphosphates of AZT and FLT are thought to be responsible for both the antiviral effects and the toxicity of these nucleoside analogues (Furman et sl., 1986; Balzarini et el., 1988a,c; Hartmann et sl., 1988; Matthes et et., 1988) . Any factor which increases the amount of triphosphate formed may therefore be expected to cause parallel increases in antiviral activity and toxicity. 5-FdUrd is already in clinical use as an anti-cancer agent. Our results show that 5-FdUrd can effect the metabolism of thymidine analogues such as AZT and FLT to some extent. This relationship has been confirmed in experiments with a human colon tumour cell line, where AZT was shown to potentiate the anti-proliferative effect of fluorouracil, a precursor of 5-FdUrd (Brunetti et al., 1989a,b,) . This must be borne in mind before consideration is given to using such a combination therapeutically, since a dose reduction might be required.
In conclusion, reducing the competition between thymidine and AZT or FLT for" phosphorylation by inhibiting thymidylate synthase with 5-FdUrd monophosphate increased the amount of AZT and FLT triphosphate formed intracellularly. However, the substrate efficiency of AZT and FLT for one or more of the phosphorylating enzymes remains as the major limitation to the rate of phosphorylation.
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Materials and Experimental procedures
Chemicals
Nucleosides and nucleotides were of the highest purity and were purchased from Sigma Chemical Co. (St Louis, MO). 5-FdUrd was purchased from Janssen (Beerse, Belgium). [5-3H]-2'-deoxyuridine (20Ci/mmol, 98% pure) and [5-3H]-3'-azido-3'deoxythymidine (AZT; 15Ci/mmol, 99% pure) were purchased from Moravek Biochemicals Inc. (Brea, CAl. FLT was a kind gift from Professor B. Oberg (Medivir, Stockholm, Sweden) and was labelled by catalytic exchange with tritium gas by Amersham International pic (Amersham, Bucks, UK). The resulting compound was expected to be [5-3H]-3' -fluoro-3'-deoxythymidine. It was -further purified before use by reverse-phase HPLC on a Novapak C18 column with 15% methanol in water at 2ml rnln" as eluting solvent. After rotary evaporation the compound was redissolved in water and stored at -20°C. The final compound was 92% pure and had a specific activity of 1.4Ci/mmol. The overall recovery was 81%.
Cell culture
CEM cells (a human CD4+ lymphocyte cell line) were grown in RPMI medium supplemented with 10% heat-inactivated fetal calf serum, antibiotics and pyruvate at 37"C in a humidified atmosphere of 5% CO 2 in air. Cell counting and viability were determined by the trypan blue exclusion method. Cells (4 x 10 5 cells/ml) were incubated for 16h with 500nM 5-FdUrd. This concentration of 5-FdUrd was chosen initially so that intracellular thymidylate synthase activity would be completely inhibited, since we suspected that any increased phosphorylation of AZT or FLT might be small and might only be seen under conditions of complete inhibition of thymidylate synthase (see the Results). Thymidylate synthase activity in intact cells was assayed by measuring the amount of tritium released into water using [5-3H]-2'-deoxyuridine as substrate precursor. Briefly, 5 x 10 6 cells were removed from the flask and incubated at 37"C for 2 h in the presence of 1 p.Ci(5nM) [5-3H]-2-deoxyuridine. One-hundred microlitres ice-cold 50% trichloroacetic acid were then added to stop the reaction and the extract kept on ice for 10 min. Five-hundred microlitres of a 100mg ml' suspension of charcoal were added and the extract thoroughly mixed. After centrifugation at 1000gfor 10 min to precipitate the charcoal, the tritiated water in the supernatant was measured by scintillation counting. This method allowed measurement of the intracellular thymidylate synthase activity of CEM cells.
0.1 f.LM [5-3H]-AZT or [5-3H]-FL T was added to the 5-FdUrdtreated cells and the cells incubated for a further 24h. This concentration, which is somewhat lower than that used in other studies, was chosen because it is closer to the physiological concentration occurring in vivo (Yarchoan et al., 1986) . Thus, effects owing to very high concentrations of AZT or FLT which cannot be expected to occur in vivo were avoided, whilst maintaining a concentration that provided maximum antiviral activity. The incubation time of 24 h was chosen so that the levels of AZT metabolites would be at a maximum (Furman et al., 1986) . We also wanted to observe the effects of the nucleoside analogues upon the natural dNTP pools after prolonged exposure, which more closely represents the situation in treated individuals, bearing in mind the fact that some AZT-induced alterations in dNTP pools have been shown to be transient (Frick et al., 1988) . Lastly, the incubation time of 24h was chosen to enable direct comparison of metabolite levels with other studies which used the same incubation time (Furman et al., 1986; Balzarini et al., 1988c; Frick et al., 1988; Hao et al., 1988) . After 24 h the cells were harvested by centrifugation and extracted with 12% cold trichloroacetic acid. The cells were incubated on ice for 10 min and then the precipitate removed by centrifugation. The acidic extract was neutralized by the amine-freon method (Chen et al., 1977) . This method of preparing cell extracts prior to HPLC analysis of nucleotides has been shown to give excellent recovery (95% or better) of dNTP (Chen et al., 1977; Harmenberg et el., 1987 Harmenberg et el., , 1990 .
HPLC analysis
Cell extracts were treated with periodate to destroy ribonucleotides (Garret and Santi, 1979) . The periodate oxidation procedure of Garrett and Santi (1979) has been shown to give excellent recovery of dNTP (95% or better) and allows accurate measurement of dNTP (Ingraham et al., 1981; Harmenberg et al., 1987 Harmenberg et al., , 1990 Anderson, 1988) . Prior to HPLC the dNTP were partially purified by retention on a weak ion-exchange cartridge; the bases produced from the rNTP in the periodate reaction were washed away with water and the partially purified, concentrated dNTP then eluted with 5M NaCI (Harmenberg et al., 1990) . HPLC analyses were performed on a Waters chromatograph equipped with a dual wavelength absorbance detector (254 and 280 nm). Results were processed using a Shimadzu C-R3A integrator. The analyses were performed on a Whatman Partisil SAX column, 0.4 x 25cm. The mobile phase was 0.5M phosphate, pH 3.5, 1.6ml rninr ' for dNTP and 20mM phosphate, pH 3.5, 1 ml rnlrr " for dNMP. 0.5-min fractions were collected, scintillant was added and the radioactivity profile determined by scintillation counting.
